Hepatic steatosis and severe fibrosis may increase risk of mortality in diabetes patients

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-12-17 05:00 GMT | Update On 2022-12-18 11:37 GMT

In individuals with type 2 diabetes, hepatic steatosis and severe fibrosis were strongly linked to chances of overall and cause-specific death, says an article published in Cardiovascular Diabetology Journal.

Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes frequently coexist. Up to 75% of type 2 diabetes mellitus patients are thought to have NAFLD, which is more than twice the rate of the general population. Due to their shared metabolic risk factors, type 2 diabetes mellitus and NAFLD not only coexist but also may interact to cause related adverse outcomes.

But further research is needed to fully understand how NAFLD affects mortality in Asian people with type 2 diabetes. So, using a population-based, national Korean cohort, Goh Eun Chung and colleagues set out to evaluate the relationship between the fatty liver index (FLI) and BARD score and overall and cause-specific mortality in individuals with type 2 diabetes mellitus.

Researchers used a database from the National Health Insurance Service that was connected to death certificate data to include patients who had undergone general health examinations between 2009 and 2012 in this study. Fatty liver index (FLI) 60 was used to define hepatic steatosis, and the BARD score was used to determine advanced hepatic fibrosis.

The key findings of this study were as:

222,242 people passed away over the 8.1-year follow-up period, dying at a mortality rate of 14.3/1000 person-years.

An FLI 60 was substantially linked to an increased risk of mortality from all causes and cause-specific causes, such as cancer, liver disease, and cardiovascular disease (CVD). An FLI 60 and fibrosis (BARD 2) were associated with higher chances of death from all causes, CVDs, cancers, and liver diseases.

In conclusion, the chances of overall and cause-specific mortality in individuals with type 2 diabetes mellitus were significantly increased by hepatic steatosis and/or severe fibrosis, as determined by the FLI and BARD scores.

Reference:

Chung, G. E., Jeong, S.-M., Cho, E. J., Yoon, J. W., Yoo, J.-J., Cho, Y., Lee, K., Shin, D. W., Kim, Y. J., Yoon, J.-H., Han, K., & Yu, S. J. (2022). The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study. In Cardiovascular Diabetology (Vol. 21, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s12933-022-01691-6

Article Source : BMC Cardiovascular Diabetology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Jacinthlyn Sylvia

Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Hepatic steatosis and severe fibrosis may increase risk of mortality in diabetes patients

Similar News

Healthy Diet Patterns Lower Type 2 Diabetes Risk Across Ethnicities: Meta-Analysis of 800,000+ Individuals shows

22 Percent of Indian Children with Diabetic Ketoacidosis Develop Kidney Injury, Reveals Hospital-Based Study

Older, White Male Smokers at Higher Risk for Diabetic Foot Ulcers: Study

This Brain Hormone May Control Blood Sugar Without Insulin: Study Suggests

Low FT4 Levels Linked to Higher Gestational Diabetes Risk: Study

Hypothyroidism May Lower Breast Cancer Risk, Especially After Menopause: Study

Age at woman's first period can offer clues about long-term health risks: Study

A new diabetes subtype identified in Sub-Saharan Africa and Black Americans, study finds